Skip to main content

Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review

The Original Article was published on 04 August 2022

Correction: Pediatr Rheumatol 20, 60 (2022)

https://doi.org/10.1186/s12969-022-00723-5

The original publication of this article [1] contained an incorrect author name. The incorrect and correct name are shown below. The original article has been updated.

Author name

  • The incorrect author name is: Naofumi Gima

  • The correct author name is: Masafumi Gima

Reference

  1. Nishi K, et al. Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review. Pediatr Rheumatol. 2022;20:60. https://doi.org/10.1186/s12969-022-00723-5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shuichi Ito.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nishi, K., Ogura, M., Tamai, N. et al. Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review. Pediatr Rheumatol 20, 76 (2022). https://doi.org/10.1186/s12969-022-00736-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12969-022-00736-0